Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
5,773,542
-
Shares change
-
+47,038
-
Total reported value, excl. options
-
$127,473,278
-
Value change
-
+$1,034,675
-
Number of buys
-
36
-
Number of sells
-
-21
-
Price
-
$22.08
Significant Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q2 2021
66 filings reported holding PGHY - INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH as of Q2 2021.
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,773,542 shares
.
Largest 10 shareholders include Whitcomb & Hess, Inc. (669,518 shares), Cerity Partners LLC (451,267 shares), CABOT WEALTH MANAGEMENT INC (437,614 shares), FLOW TRADERS U.S. LLC (366,528 shares), Kestra Advisory Services, LLC (314,226 shares), PFS INVESTMENTS INC. (287,847 shares), Legacy Capital Wealth Partners, LLC (257,722 shares), Sowell Financial Services LLC (198,224 shares), CENTAURUS FINANCIAL, INC. (176,870 shares), and LINCOLN NATIONAL CORP (172,829 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.